-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Product Theaters

Saturday, December 5, 2020

Saturday | Sunday | Monday | top

11:00 AM-12:00 PM

A Discussion of Efficacy and Safety on a Treatment Option for Adults With Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)
Advances in the Treatment of aTTP
A New Treatment Option for Patients with Acute Myeloid Leukemia
Introducing BLENREP (belantamab mafodotin-blmf) for Injection, for Intravenous Use
NGS Solutions That Help Simplify Your Journey to Answers in Hemato-Oncology Research
Study Results from the First and Only Randomized Pivotal Trial in R/R DLBCL

Sunday, December 6, 2020

Saturday | Sunday | Monday | top

11:00 AM-12:00 PM

An Anti-CD38 Directed Antibody for the Treatment for Appropriate Patients with Relapsed Refractory Multiple Myeloma
A Targeted Therapeutic Approach for Relapsed or Refractory FLT3m+ AML Patients
A Treatment Option for Adult Patients With Newly Diagnosed CP Ph+ CML or Patients With CML Resistant/Intolerant to Prior TKI Therapy
A Treatment Option for Patients with Myelodysplastic Syndromes
MONJUVI (tafasitamab-cxix) For Use As Second-line Therapy in Adult Patients with R/R DLBCL, In Combination With Lenalidomide
Redefining Approaches in Early-Line Multiple Myeloma Treatment

Monday, December 7, 2020

Saturday | Sunday | Monday | top

10:30 AM-11:30 AM

clonoSEQ and MRD Assessment in the Management of Lymphoid Malignancies
Exploring Outcomes With Fixed-Duration Treatment in CLL and New Evidence in First-Line AML: Pivotal Clinical Trial Data That Supports Treatment Decisions and Patient Care
Scientific Exploration of Novel Targets for Hematology: A Glimpse into Areas of Research and Development
Trust the Experience of a rFVIIa Product Used for a Wide Range of Indications